MMP-14 also increases cancer invasiveness by cleaving the N-terminal heparin-binding domain of heparin-binding EGF-like growth factor (HB-EGF) to convert it into a heparin-independent growth factor [208]. This evidence concerns the gene HBEGF and cancer.